Navigation Links
BioMarin Announces Third Quarter 2009 Financial Results
Date:10/28/2009

NOVATO, Calif., Oct. 28 /PRNewswire-FirstCall/ -- 

    Financial Highlights ($ in millions, except per share data)

    Item                   Q3 2009                Q3 2008 Comparison
    Total BioMarin
     Revenue               $80.8                  11% increase
    Total Net Product
     Revenue               $78.4                  16% increase
    Naglazyme Net
     Product Revenue       $42.1                  26% increase
    Aldurazyme BioMarin
     Net Product Revenue   $14.6                  $20.7 ($5.6 net inventory
                                                  transfer)
    Kuvan Net Product
     Revenue               $21.7                  57% increase
    GAAP Net Income        $6.6                   $0.8
    GAAP Net Income
     per share             $0.07 (basic),         $0.01 (basic and diluted)
                            $0.06 (diluted)
    Non-GAAP Net Income    $15.5                  $8.2
    Non-GAAP Net Income
     per share             $0.16 (basic),         $0.08 (basic and diluted)
                            $0.13 (diluted)

BioMarin Pharmaceutical Inc. (Nasdaq: BMRN) today announced financial results for the third quarter ended September 30, 2009. GAAP net income was $6.6 million ($0.06 per diluted share) for the third quarter of 2009, compared to GAAP net income of $0.8 million ($0.01 per diluted share) for the third quarter of 2008. Non-GAAP net income was $15.5 million ($0.13 per diluted share) for the third quarter of 2009, compared to non-GAAP net income of $8.2 million ($0.08 per diluted share) for the third quarter of 2008. Non-GAAP net income excludes non-cash stock compensation expense, certain nonrecurring material items and the tax effect of the adjustments. The reconciliation of the non-GAAP measures to the estimated GAAP net income is detailed in the table provided at the end of
'/>"/>

SOURCE BioMarin Pharmaceutical Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18

Related medicine technology :

1. BioMarin to Present at the Oppenheimer Healthcare Conference
2. BioMarin Acquires Huxley Pharmaceuticals, Inc.
3. BioMarin Initiates Phase 2 Clinical Study of PEG-PAL in PKU
4. BioMarin Initiates Phase 1/2 Clinical Trial for GALNS for Morquio A Syndrome
5. BioMarin Announces Positive Results From Phase 2A Clinical Study of 6R-BH4 in Sickle Cell Disease
6. BioMarin Initiates Phase 1 Clinical Study of PEG-PAL in PKU
7. BioMarin Announces FDA Approval for Kuvan
8. BioMarin Partner AnGes MG, Inc. Submits BLA to Japanese Ministry of Health
9. Rigel Announces Presentations at Two Investor Conferences
10. Onyx Pharmaceuticals Announces Third Quarter 2009 Financial Results Teleconference and Webcast
11. STAAR Surgical Announces Third Quarter 2009 Earnings Release Date and Conference Call
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/16/2009)... Engineered Technologies (HDT), a leader in the development ... for the mechanical development of the Modular Prosthetic ... technology that will give patients improved, dexterous control ... sense of touch. ,, As part of ... Prosthetics 2009 (RP2009) project, the MPL overcomes the ...
(Date:12/16/2009)... International, Inc. (OTCQX: DATA), a technology and ... for the clinical trials industry, today announced ... Software. This release advances the Company,s ... and introduces two new mechanisms for facilitating ... Center(TM) and the DATATRAK Learning Manager(TM). ...
(Date:12/16/2009)... Scientists at,deCODE genetics, Inc. (Nasdaq: DCGN ... a version of a common single-letter variant in ... major impact on susceptibility to type 2,diabetes (T2D). ... only large, but unusual:,if an individual inherits it ... by more than 30% compared to those who ...
Breaking Medicine Technology:HDT Develops Robotic Arm Technology for DARPA's Revolutionizing Prosthetics 2009 Program 2DATATRAK's eClinical(TM) 9.0 Software Release furthers Vision of DATATRAK ONE(TM) 2DATATRAK's eClinical(TM) 9.0 Software Release furthers Vision of DATATRAK ONE(TM) 3DATATRAK's eClinical(TM) 9.0 Software Release furthers Vision of DATATRAK ONE(TM) 4deCODE Discovers a Major Risk Factor for Type 2 Diabetes Dependent on Parent of Origin 2deCODE Discovers a Major Risk Factor for Type 2 Diabetes Dependent on Parent of Origin 3deCODE Discovers a Major Risk Factor for Type 2 Diabetes Dependent on Parent of Origin 4Main Ingredients in Household Dust Come From Outdoors 61132 1U S Army Special Forces Operators Reluctant to Seek Treatment for Posttraumatic Stress Disorder 61127 1U S Army Special Forces Operators Reluctant to Seek Treatment for Posttraumatic Stress Disorder 61127 2MAP Pharmaceuticals to Present at the Lazard Capital Markets 6th Annual Healthcare Conference 6155 1
... BNVI ) announced today that its drug candidate ... clinical testing after the,successful completion of a second Phase ... was conducted to identify the maximum,tolerated dose of BZL101 ... novel, oral, anticancer treatment. A total of 27 women ...
... 3 Sirion Therapeutics, Inc., a,privately held ... two investigational drugs in development for,treatment of ... at,upcoming ophthalmology meetings: At the American Uveitis ... Marquis, Atlanta),preliminary results will be presented from ...
Other Medicine Technology:Bionovo Advances BZL101 to Phase 2 Clinical Trials After Positive Phase 1 Results for Metastatic Breast Cancer 2Bionovo Advances BZL101 to Phase 2 Clinical Trials After Positive Phase 1 Results for Metastatic Breast Cancer 3Bionovo Advances BZL101 to Phase 2 Clinical Trials After Positive Phase 1 Results for Metastatic Breast Cancer 4Durezol(TM) in the Treatment of Uveitis and Ganciclovir in the Treatment of Herpetic Keratitis: Studies of Treatments for Leading Causes of Blindness to Be Presented 2Durezol(TM) in the Treatment of Uveitis and Ganciclovir in the Treatment of Herpetic Keratitis: Studies of Treatments for Leading Causes of Blindness to Be Presented 3Durezol(TM) in the Treatment of Uveitis and Ganciclovir in the Treatment of Herpetic Keratitis: Studies of Treatments for Leading Causes of Blindness to Be Presented 4Durezol(TM) in the Treatment of Uveitis and Ganciclovir in the Treatment of Herpetic Keratitis: Studies of Treatments for Leading Causes of Blindness to Be Presented 5
(Date:12/17/2009)... Dec. 17 Reportlinker.com announces ... is available in its catalogue: ,, ... assessment of the competitive environment is ... highest priority management responsibilities, the task ... profitability. Timely and factual competitive intelligence ...
(Date:12/17/2009)... Ohio, Dec. 17 Good Samaritan Hospital is ... health issues with the launch of the Good Samaritan ... The center is designed to help treat two common ... and slippage of the bladder, uterus or rectum (pelvic ... degree of urinary leakage and one out of three ...
(Date:12/17/2009)... Canadian teenagers are among the largest consumers of cannabis ... young brains are worse than originally thought, according to ... from the Research Institute of the McGill University Health ... Disease , suggests that daily consumption of cannabis in ... irreversible long-term effect on the brain. , "We wanted ...
(Date:12/17/2009)... might someday ease accompanying lung infections , , THURSDAY, Dec. ... when infected with the swine flu virus, and researchers ... A key to the severity of the illness appears ... helps the immune system fight off germs and disease. ... patients at 10 Spanish hospitals last summer found the ...
(Date:12/17/2009)... delivered during computed tomography examinations underscore the important role ... and protecting patients, according to the American Society of ... ... Albuquerque, NM (Vocus) December 16, 2009 -- Two ... examinations underscore the important role that competent, educated CT ...
Breaking Medicine News(10 mins):Health News:Reportlinker Adds Top Ten World's Leading Life Science Intermediates Companies 2Health News:Good Samaritan Hospital Launches Women's Center For Bladder & Pelvic Health 2Health News:Good Samaritan Hospital Launches Women's Center For Bladder & Pelvic Health 3Health News:ASRT Supports Efforts to Minimize CT Radiation Dose 2Health News:ASRT Supports Efforts to Minimize CT Radiation Dose 3Health News:ASRT Supports Efforts to Minimize CT Radiation Dose 4
... PRGO ; TASE) today announced that its ... per share, payable on June 20, 2008 to,shareholders ... Company is a leading global healthcare supplier that ... products, active pharmaceutical ingredients,(API) and consumer products. The ...
... IRVINE, Calif., May 1 Cardiogenesis,Corporation (Pink Sheets: ... its first quarter ended March 31, 2008 prior ... company also said that President Richard P.,Lanigan and ... R.,Abbott will host an investor conference call that ...
... Geriatrics Society ... Symposium, ... in geriatric health and disease was presented at The,American Geriatrics Society ... of Life in Older People." Leading,scientists and physicians shared the newest ...
... improved physical performance, ALEXANDRIA, Va., May 1 ... fixes" like caffeine and,performance-enhancing supplements, which claim to ... lives, they are losing sight of what,experts say ... sleep., According to the 2008 Better Sleep ...
... in Ozone and Particle Pollution Have,Stalled, WASHINGTON, ... annual report card on air pollution today, ranking,cities ... particle,pollution, year-round particle pollution and ozone pollution. For ... Pennsylvania, tops one of,the most polluted lists in ...
... NASHVILLE, Tenn., April 30 Brookdale Senior,Living Inc. (NYSE: ... release its first,quarter 2008 financial results after the market ... a conference call to discuss the results on,Thursday, May ... can be accessed by,dialing (866) 845-7252 (from within the ...
Other Medicine News:Health News:Probiotics May Benefit Health and Quality of Life of Older People 2Health News:Probiotics May Benefit Health and Quality of Life of Older People 3Health News:Probiotics May Benefit Health and Quality of Life of Older People 4Health News:Probiotics May Benefit Health and Quality of Life of Older People 5Health News:Americans Get Physical After a Good Night in Bed 2Health News:Americans Get Physical After a Good Night in Bed 3Health News:Americans Get Physical After a Good Night in Bed 4Health News:American Lung Association Issues State of the Air Report: First City Outside California (Pittsburgh) Tops One of the Most-Polluted Lists 2Health News:American Lung Association Issues State of the Air Report: First City Outside California (Pittsburgh) Tops One of the Most-Polluted Lists 3Health News:American Lung Association Issues State of the Air Report: First City Outside California (Pittsburgh) Tops One of the Most-Polluted Lists 4Health News:Brookdale Announces First Quarter 2008 Release and Earnings Call 2
Rapid, visual assay for the presumptive qualitative detection of Respiratory Syncytial Virus (RSV) directly from nasopharyngeal specimens in neonatel and pediatric patients....
Rapid immunochromatographic membrane test for RSV. Accepts nasopharyngeal washes, aspirates, and swabs....
A direct enzyme immunoassay for detection of gr. A rotavirus in fecal specimens....
ELISA for Anti-Proteinase 3 PR3 (cANCA)....
Medicine Products: